Blood transcriptional signatures for tuberculosis testing

Simon C Mendelsohn, Stanley Kimbung Mbandi, Mark Hatherill, Thomas J Scriba
2020 The Lancet Respiratory Medicine  
SCM received training in research that was supported by the Fogarty International Center of the US National Institutes of Health (number D43 TW010559). TJS is a co-inventor of patents for the Zak16, Suliman4, and Penn-Nicholson6 (RISK6) signatures that were assessed in the Article by Turner and colleagues. 4 SKM and MH declare no competing interests.
doi:10.1016/s2213-2600(20)30045-x pmid:32178777 pmcid:PMC8919958 fatcat:xgyosjhuzra5dbvxocwhqlktgi